RxDoctor Payments Data

Sean Anderson, MD

Family Medicine · Amarillo, TXNPI 1699118745

Payments from drug & device makers

$729in general payments, 2019–2025

Across 37 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$99
  • Johnson & Johnson$93
  • AstraZeneca$67
  • AbbVie$66
  • GSK$54
  • Dexcom, Inc.$39
  • plus $310 from 14 others

What the payments were for

  • Food & beverage$64488%
  • Education$8512%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$729 in reported general payments places this provider in the 55th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$44,140
Medicare patients
127
Services billed
611

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$52,807
MounjaroTirzepatide35$42,686
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$16,773
JardianceEmpagliflozin13$16,266
EliquisApixaban14$8,224
FarxigaDapagliflozin Propanediol14$7,742
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$3,729
Gabapentin110$1,989
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$1,355
Albuterol Sulfate HfaAlbuterol Sulfate44$1,346
Ventolin HfaAlbuterol Sulfate15$1,330
Pregabalin27$1,201
Fluticasone Propionate40$1,143
Omeprazole104$1,095
Levothyroxine Sodium153$1,082

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$29$52,80756 claims
GSKTrelegy Ellipta$54$16,77327 claims
Boehringer IngelheimJardiance$18$16,26613 claims
PfizerEliquis$34$8,22414 claims
AstraZenecaFarxiga$67$7,74214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Amarillo

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →